JP2022513597A5 - - Google Patents
Info
- Publication number
- JP2022513597A5 JP2022513597A5 JP2021525191A JP2021525191A JP2022513597A5 JP 2022513597 A5 JP2022513597 A5 JP 2022513597A5 JP 2021525191 A JP2021525191 A JP 2021525191A JP 2021525191 A JP2021525191 A JP 2021525191A JP 2022513597 A5 JP2022513597 A5 JP 2022513597A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antisense oligonucleotide
- administered
- dose
- nucleosides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024213950A JP2025023319A (ja) | 2018-12-14 | 2024-12-06 | 筋萎縮性側索硬化症を治療及び予防するための組成物及び方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779916P | 2018-12-14 | 2018-12-14 | |
| US62/779,916 | 2018-12-14 | ||
| US201962807603P | 2019-02-19 | 2019-02-19 | |
| US62/807,603 | 2019-02-19 | ||
| US201962840879P | 2019-04-30 | 2019-04-30 | |
| US62/840,879 | 2019-04-30 | ||
| PCT/US2019/065936 WO2020123783A1 (en) | 2018-12-14 | 2019-12-12 | Compositions and methods for treating and preventing amyotrophic lateral sclerosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213950A Division JP2025023319A (ja) | 2018-12-14 | 2024-12-06 | 筋萎縮性側索硬化症を治療及び予防するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513597A JP2022513597A (ja) | 2022-02-09 |
| JP2022513597A5 true JP2022513597A5 (cg-RX-API-DMAC10.html) | 2022-10-27 |
| JP7612575B2 JP7612575B2 (ja) | 2025-01-14 |
Family
ID=69160351
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525191A Active JP7612575B2 (ja) | 2018-12-14 | 2019-12-12 | 筋萎縮性側索硬化症を治療及び予防するための組成物及び方法 |
| JP2024213950A Pending JP2025023319A (ja) | 2018-12-14 | 2024-12-06 | 筋萎縮性側索硬化症を治療及び予防するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213950A Pending JP2025023319A (ja) | 2018-12-14 | 2024-12-06 | 筋萎縮性側索硬化症を治療及び予防するための組成物及び方法 |
Country Status (20)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016040748A1 (en) | 2014-09-12 | 2016-03-17 | Ionis Pharmaceuticals, Inc. | Compositions and methods for detection of smn protein in a subject and treatment of a subject |
| JP7506606B2 (ja) | 2018-01-25 | 2024-06-26 | バイオジェン・エムエイ・インコーポレイテッド | 脊髄性筋萎縮症を治療する方法 |
| MA54383A (fr) | 2018-12-06 | 2021-10-13 | Biogen Ma Inc | Protéine neurofilamenteuse pour guider une intervention thérapeutique dans la sclérose laterale amyotrophique |
| EP3924739A1 (en) | 2019-02-12 | 2021-12-22 | Biogen MA Inc. | Biomarkers of progressive multifocal leukoencephalopathy |
| KR20230172502A (ko) * | 2021-03-31 | 2023-12-22 | 바이오젠 엠에이 인코포레이티드 | 근위축성 측삭경화증의 치료 |
| WO2025045130A1 (zh) * | 2023-08-29 | 2025-03-06 | 石药集团中奇制药技术(石家庄)有限公司 | 一种抑制sod1基因表达的dsrna分子及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005504020A (ja) | 2001-07-03 | 2005-02-10 | アイシス・ファーマシューティカルス・インコーポレーテッド | ヌクレアーゼ耐性キメラオリゴヌクレオチド |
| WO2013134403A1 (en) * | 2012-03-06 | 2013-09-12 | The Washington University | Method of treating neurodegenerative diseases with microrna regulators |
| SI3119888T1 (sl) * | 2014-03-19 | 2021-11-30 | Ionis Pharmaceuticals, Inc. | Sestavki za moduliranje izražanja ataksina 2 |
| HUE050704T2 (hu) | 2014-04-01 | 2020-12-28 | Biogen Ma Inc | Összetételek a SOD-1 expressziójának modulálására |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| EP3618839A4 (en) * | 2017-05-05 | 2021-06-09 | Voyager Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| WO2018218219A1 (en) * | 2017-05-26 | 2018-11-29 | University Of Miami | Determining onset of amyotrophic lateral sclerosis |
-
2019
- 2019-12-06 TW TW108144617A patent/TWI906204B/zh active
- 2019-12-11 UY UY0001038506A patent/UY38506A/es not_active Application Discontinuation
- 2019-12-12 CN CN201980080996.2A patent/CN113330116A/zh active Pending
- 2019-12-12 BR BR112021011334-7A patent/BR112021011334A2/pt unknown
- 2019-12-12 US US17/291,199 patent/US20220073930A1/en active Pending
- 2019-12-12 MY MYPI2021003225A patent/MY209775A/en unknown
- 2019-12-12 MX MX2021005086A patent/MX2021005086A/es unknown
- 2019-12-12 CN CN202411184930.7A patent/CN119185345A/zh active Pending
- 2019-12-12 CN CN202411184883.6A patent/CN118987017A/zh active Pending
- 2019-12-12 WO PCT/US2019/065936 patent/WO2020123783A1/en not_active Ceased
- 2019-12-12 AU AU2019396522A patent/AU2019396522B2/en active Active
- 2019-12-12 KR KR1020217020529A patent/KR102821047B1/ko active Active
- 2019-12-12 JP JP2021525191A patent/JP7612575B2/ja active Active
- 2019-12-12 KR KR1020257019188A patent/KR20250090384A/ko active Pending
- 2019-12-12 EP EP19836331.9A patent/EP3894557A1/en active Pending
- 2019-12-12 SG SG11202103415WA patent/SG11202103415WA/en unknown
- 2019-12-12 CA CA3115549A patent/CA3115549A1/en active Pending
- 2019-12-12 CR CR20210384A patent/CR20210384A/es unknown
-
2021
- 2021-04-29 CL CL2021001136A patent/CL2021001136A1/es unknown
- 2021-06-09 JO JOP/2021/0143A patent/JOP20210143A1/ar unknown
- 2021-06-09 IL IL283833A patent/IL283833A/en unknown
- 2021-06-09 PH PH12021551365A patent/PH12021551365A1/en unknown
- 2021-06-23 CO CONC2021/0008187A patent/CO2021008187A2/es unknown
-
2024
- 2024-12-06 JP JP2024213950A patent/JP2025023319A/ja active Pending
-
2026
- 2026-07-06 AU AU2026205314A patent/AU2026205314A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7198298B2 (ja) | Sod-1発現を調節するための組成物 | |
| RU2566724C9 (ru) | Композиции и способы модуляции smn2 сплайсинга у субъекта | |
| US20250270555A1 (en) | Organic compositions to treat beta-catenin-related diseases | |
| JP2021104035A (ja) | アタキシン2の発現を調節するための組成物 | |
| JP2022501040A (ja) | 17β−HSD13型(HSD17B13)の発現を阻害するためのRNAi剤、その組成物、および使用方法 | |
| US20140378533A1 (en) | Modulation of rna by repeat targeting | |
| TW201920227A (zh) | 用於抑制脂蛋白元C-III (APOC3)表現之RNAi試劑及組合物 | |
| HK1246648A1 (en) | Compositions and methods for modulation of smn2 splicing in a subject | |
| CN104994884B (zh) | 对脂蛋白脂肪酶缺乏(lpld)群体中的载脂蛋白c-iii(apociii)表达的调节 | |
| JP2022527105A (ja) | Ube3a-atsを調節するための化合物及び方法 | |
| JP7612575B2 (ja) | 筋萎縮性側索硬化症を治療及び予防するための組成物及び方法 | |
| TW202016305A (zh) | Apol1表現之調節劑 | |
| KR20230108728A (ko) | 앤지오텐시노겐 발현을 조절하기 위한 화합물 및 방법 | |
| CN119365598A (zh) | 用于治疗单基因神经发育障碍的组合物和方法 | |
| EP4100022B1 (en) | Sirna, medical compositions, and methods for treating diabetes using the same | |
| RU2021112868A (ru) | Составы и способы лечения и предотвращения бокового амиотрофического склероза | |
| RU2024121642A (ru) | Составы и способы лечения и предотвращения бокового амиотрофического склероза | |
| CN121358862A (zh) | 用于治疗肾脏疾病的组合物和方法 | |
| WO2019161294A1 (en) | Targeting lipid metabolism and free fatty acid (ffa) oxidation to treat diseases mediated by resident memory t cells (trm) | |
| HK40120557A (en) | Compounds and methods for modulating angiotensinogen expression | |
| CN121152878A (zh) | 用于抑制补体因子B (CFB)表达的RNAi剂、其药物组合物和使用方法 | |
| HK40054232B (en) | Modulators of pnpla3 expression | |
| HK40000192B (en) | Compositions and methods for modulation of smn2 splicing in a subject | |
| HK40025555A (en) | Compositions and methods for modulation of smn2 splicing in a subject |